Bisphosphonate-related osteonecrosis of the jaw and dental implants.

J Istanb Univ Fac Dent 2016 12;50(1):59-64. Epub 2016 Jan 12.

Department of Oral Implantology Faculty of Dentistry Istanbul University Turkey.

Bisphosphonate (BP) is one of the possible riskfactors in the osteonecrosis of the jaw (ON J). Surgical interventions during or after the course of treatment by using BPs may expose the patient under this risk. Animal studies, human studies, case reports, and systematic reviews are used to show the relationship between the use of bisphosphonates and dental implants. In this review data about bisphosphonaterelated osteonecrosis of the jaw (BRON J): incidence, prevention and treatment modalities for the patients who are scheduled for dental implant treatment plan and who have been already treated by dental implants will be investigated. Various views for the relationship between dental implants and bisphosphonates will be analyzed depending on the multifactors: duration, route of uptake, dosage of the drug and patient's other medications that affect the effects of bisphosphonate. All patients treated with this drug must be informed about the risk of implant loss or possibility of osteonecrosis.

Download full-text PDF

Source
http://dx.doi.org/10.17096/jiufd.24812DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573455PMC
January 2016

Publication Analysis

Top Keywords

dental implants
16
osteonecrosis jaw
12
dental
5
implant treatment
4
treated dental
4
plan treated
4
treatment plan
4
implants will
4
investigated views
4
implants bisphosphonates
4
relationship dental
4
views relationship
4
dental implant
4
will investigated
4
modalities patients
4
bisphosphonaterelated osteonecrosis
4
data bisphosphonaterelated
4
review data
4
implants review
4
jaw bron
4

Similar Publications